ADC Therapeutics SA (ADCT) income statement
ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.28−0.02 (-1.54%)
Close on Nov 20, 2026Market cap $163.42MP/E –Yield –
ADC Therapeutics SA financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $163.42MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | 92.9% | 91.6% | 96.4% | 98.4% | 95.9% | – | 100.0% | – | – |
| Operating margin | -149.3% | -184.4% | -238.6% | -58.8% | -771.6% | – | -5,102.5% | -11,047.5% | – |
| Pre-tax margin | -174.1% | -220.4% | -280.9% | -69.9% | -741.5% | – | -4,953.1% | -10,778.2% | – |
| Net profit margin | -175.3% | -222.8% | -345.1% | -74.9% | -678.2% | – | -4,977.9% | -10,797.9% | – |
| Free cash flow margin | -173.8% | -176.0% | -175.3% | -66.2% | -698.2% | – | -5,211.1% | -10,728.6% | – |
| Returns on capital | |||||||||
| Return on equity | 73.4% | 90.0% | 697.8% | -134.6% | -94.0% | -110.3% | -98.1% | -65.6% | – |
| Return on assets | -44.2% | -46.6% | -56.8% | -28.3% | -40.7% | -75.6% | -84.6% | – | – |
| Return on tangible assets | -44.2% | -46.6% | -56.8% | -29.1% | -41.7% | -78.1% | -90.1% | – | – |
| Return on invested capital | 21.4% | 22.8% | – | 43.0% | 145.6% | 497.2% | 2,146.2% | – | – |
| Return on capital employed | -49.1% | -49.4% | -47.7% | -25.9% | -51.5% | -74.2% | -101.4% | – | – |
| Return on total capital | 63.0% | 64.5% | – | -72.6% | -84.2% | -90.4% | -107.4% | – | – |
| NOPAT | -$95.98M | -$103.22M | -$131.13M | -$97.44M | -$206.76M | -$173.22M | -$94.33M | -$99.49M | – |
| Cash flow quality | |||||||||
| OCF / Sales | -173.5% | -174.8% | -170.6% | -65.9% | -688.1% | – | -5,195.8% | -10,645.8% | – |
| OCF / Net income | 0.99 | 0.78 | 0.49 | 0.88 | 1.01 | 0.69 | 1.04 | 0.99 | – |
| FCF / OCF | 100.2% | 100.7% | 102.7% | 100.5% | 101.5% | 100.5% | 100.3% | 100.8% | – |
| FCF / Net income | 0.99 | 0.79 | 0.51 | 0.88 | 1.03 | 0.69 | 1.05 | 0.99 | – |
| Unlevered free cash flow | -$100.65M | -$85.04M | -$85.31M | -$109.98M | -$222.32M | -$165.64M | -$121.82M | -$122.31M | – |
| Levered free cash flow | -$141.44M | -$124.70M | -$121.90M | -$139.00M | -$236.81M | -$169.53M | -$121.94M | -$122.31M | – |
| Efficiency | |||||||||
| Asset turnover | 0.25 | 0.21 | 0.16 | 0.38 | 0.06 | 0.00 | 0.02 | – | – |
| Fixed asset turnover | 32.06 | 13.24 | 15.50 | 56.57 | 11.91 | 0.00 | 1.70 | – | – |
| Receivables turnover | – | – | – | 4.07 | 2.24 | – | – | – | – |
| Days sales outstanding | – | – | – | 89.7 | 162.6 | – | – | – | – |
| Payables turnover | 0.43 | 0.35 | 0.18 | 0.27 | 0.16 | 0.00 | 0.00 | – | – |
| Days payables outstanding | 856.3 | 1,030.7 | 2,014.8 | 1,350.7 | 2,274.2 | – | – | – | – |
| Inventory turnover | 1.80 | 0.65 | 0.18 | 0.28 | 0.25 | – | – | – | – |
| Days inventory outstanding | 202.6 | 565.3 | 2,038.6 | 1,282.4 | 1,457.1 | – | – | – | – |
| Operating cycle | – | – | – | 1,372.1 | 1,619.7 | – | – | – | – |
| Cash conversion cycle | – | – | – | 21.4 | -654.5 | – | – | – | – |
| CapEx to revenue | 0.32% | 1.2% | 4.6% | 0.33% | 10.1% | – | 15.3% | 82.8% | – |
| CapEx to OCF | -0.19% | -0.70% | -2.7% | -0.50% | -1.5% | -0.47% | -0.29% | -0.78% | – |
| Liquidity | |||||||||
| Current ratio | 4.37 | 3.62 | 4.97 | 5.31 | 7.10 | 11.14 | 6.15 | – | – |
| Quick ratio | 4.31 | 3.59 | 4.73 | 5.16 | 6.95 | 11.14 | 6.15 | – | – |
| Cash ratio | 3.72 | 3.12 | 4.12 | 3.98 | 6.31 | 10.86 | 5.79 | – | – |
| Working capital | $236.17M | $210.79M | $268.62M | $353.04M | $451.25M | $410.01M | $102.66M | – | – |
| Net current asset value | -$202.65M | -$233.37M | -$166.74M | $23.57M | $73.30M | $272.26M | $96.08M | – | – |
| Leverage | |||||||||
| Total debt | $3.00M | $0 | – | $12.47M | $93.73M | $38.41M | $0 | – | – |
| Net debt | -$258.34M | -$250.87M | – | -$313.97M | -$372.82M | -$400.79M | -$115.55M | – | – |
| Debt / Equity | -0.02 | -0.00 | – | 0.16 | 0.61 | 0.11 | 0.00 | – | – |
| Debt ratio | 0.93% | 0.00% | – | 2.5% | 15.2% | 7.5% | 0.00% | – | – |
| Assets to equity | -1.74 | -1.59 | -2.39 | 6.18 | 4.01 | 1.53 | 1.24 | – | – |
| Long-term debt to assets | – | – | – | – | 14.1% | 6.8% | 0.00% | – | – |
| Long-term debt to equity | – | – | – | – | 0.57 | 0.10 | 0.00 | – | – |
| Total debt / Capitalization | -1.6% | -0.00% | – | 13.6% | 37.8% | 10.3% | 0.00% | – | – |
| Long-term debt / Capitalization | – | – | – | – | 36.1% | 9.4% | 0.00% | – | – |
| Cash flow to debt | -4,705.8% | – | – | -1,108.8% | -249.0% | -439.3% | – | – | – |
| Intangibles to total assets | – | – | – | 2.9% | 2.2% | 2.0% | 6.1% | – | – |
| Interest coverage | |||||||||
| EBIT / Interest expense | -2.35 | -2.60 | -3.58 | -3.36 | -14.27 | -44.51 | -765.38 | – | – |
| Per share | |||||||||
| Revenue per share | 0.65 | 0.72 | 0.85 | 2.60 | 0.44 | 0.00 | 0.04 | 0.02 | – |
| EPS (basic) | -1.12 | -1.62 | -2.94 | -2.01 | – | -3.77 | -2.36 | -2.64 | – |
| EPS (diluted) | -1.12 | -1.62 | -2.94 | -2.01 | – | -3.77 | -2.36 | -2.64 | – |
| Book value per share | -1.48 | -2.05 | -1.80 | 0.99 | 2.01 | 4.37 | 2.13 | 2.64 | 5.26 |
| Tangible book value per share | -1.48 | -2.05 | -1.80 | 0.81 | 1.83 | 4.24 | 1.97 | 2.64 | 5.26 |
| Cash per share | 2.08 | 2.54 | 3.39 | 4.05 | 6.08 | 5.72 | 2.22 | 2.90 | 5.55 |
| Operating cash flow per share | -1.12 | -1.25 | -1.44 | -1.72 | -3.04 | -2.20 | -2.33 | -2.54 | – |
| Free cash flow per share | -1.12 | -1.26 | -1.48 | -1.72 | -3.09 | -2.21 | -2.34 | -2.56 | – |
| CapEx per share | 0.0021 | 0.0088 | 0.04 | 0.0085 | 0.04 | 0.01 | 0.0069 | 0.02 | – |
| Valuation at period end | |||||||||
| Market cap | $397.57M | $192.41M | $134.88M | $296.55M | $1.55B | $1.67B | – | – | – |
| Enterprise value | $162.83M | -$81.86M | -$161.19M | -$84.31M | $1.11B | $1.55B | – | – | – |
| P/S | 4.9x | 2.7x | 1.9x | 1.4x | 45.7x | – | – | – | – |
| P/B | -2.1x | -0.9x | -0.9x | 3.7x | 10.1x | 5.0x | – | – | – |
| P/TBV | -2.1x | -0.9x | -0.9x | 4.6x | 11.0x | 5.1x | – | – | – |
| P/Gross profit | – | – | 2.0x | 1.4x | 47.7x | – | – | – | – |
| P/OCF | -2.8x | -1.6x | -1.1x | -2.1x | -6.6x | -9.9x | – | – | – |
| EV/Sales | 2.0x | -1.2x | -2.3x | -0.4x | 32.8x | – | – | – | – |
| EV/Gross profit | – | – | -2.4x | -0.4x | 34.2x | – | – | – | – |
| EV/EBIT | – | 0.6x | 1.0x | 0.7x | – | – | – | – | – |
| EV/OCF | -1.2x | 0.7x | 1.4x | 0.6x | -4.8x | -9.2x | – | – | – |
| EV/FCF | – | 0.7x | 1.3x | 0.6x | – | – | – | – | – |
| Earnings yield | -35.9% | -82.0% | -178.0% | -53.0% | -14.8% | -14.8% | – | – | – |
| FCF yield | -35.6% | -64.8% | -90.4% | -46.9% | -15.3% | -10.2% | – | – | – |
| Shareholder yield | |||||||||
| Buyback yield | – | – | – | – | – | -26.0% | – | – | – |
| Shareholder yield | – | – | – | – | – | -26.0% | – | – | – |
| Cost structure | |||||||||
| R&D to revenue | 127.8% | 154.8% | 182.8% | 88.8% | 465.8% | – | 4,595.6% | 10,378.3% | – |
| SG&A to revenue | 98.2% | 121.3% | 152.2% | 68.4% | – | – | – | – | – |
| Stock-based comp to revenue | 8.5% | 9.3% | 19.4% | 23.5% | 178.3% | – | 47.7% | 41.1% | – |
| Per employee | |||||||||
| Total employees | 188 | 263 | 273 | 317 | 312 | 208 | 208 | 208 | 208 |
| Revenue per employee | $432.75K | $269.34K | $254.79K | $662.17K | $108.71K | $0 | $11.25K | $5.48K | – |
| Gross profit per employee | – | – | $245.53K | $651.76K | $104.24K | $0 | $11.25K | – | – |
| Operating profit per employee | -$646.27K | -$496.78K | -$608.01K | -$389.10K | -$838.85K | -$1.05M | -$574.03K | -$605.49K | – |
| Net income per employee | -$758.63K | -$600.17K | -$879.32K | -$495.67K | -$737.26K | -$1.18M | -$560.02K | -$591.81K | – |
| Free cash flow per employee | -$752.33K | -$474.15K | -$446.53K | -$438.48K | -$759.00K | -$815.05K | -$586.25K | -$588.01K | – |
| Growth | |||||||||
| Revenue 1Y growth | 14.9% | 1.8% | -66.9% | 518.9% | – | -100.0% | 105.3% | – | – |
| Revenue 3Y CAGR | -27.1% | 27.8% | – | 347.6% | 209.9% | – | – | – | – |
| Revenue 5Y CAGR | – | 97.8% | 127.6% | – | – | – | – | – | – |
| Gross profit 1Y growth | 16.4% | -3.2% | -67.6% | 535.2% | – | -100.0% | – | – | – |
| Gross profit 3Y CAGR | -28.5% | 25.9% | – | 345.3% | – | – | – | – | – |
| Gross profit 5Y CAGR | – | 94.4% | – | – | – | – | – | – | – |
| EBIT 1Y growth | 7.0% | 21.3% | -34.6% | 52.9% | -19.4% | -83.6% | 5.2% | – | – |
| Net income 1Y growth | 9.6% | 34.2% | -52.8% | 31.7% | 6.6% | -111.4% | 5.4% | – | – |
| Diluted EPS 1Y growth | 30.9% | 44.9% | -46.3% | – | – | -59.7% | 10.6% | – | – |
| Operating cash flow 1Y growth | -14.0% | -4.3% | 14.2% | 40.7% | -38.3% | -38.8% | -0.18% | – | – |
| Free cash flow 1Y growth | -13.4% | -2.3% | 12.3% | 41.3% | -39.7% | -39.0% | 0.30% | – | – |
| CapEx 1Y growth | -69.6% | -73.0% | 368.1% | -80.0% | 328.2% | 123.7% | -62.1% | – | – |
| CapEx 3Y CAGR | -27.3% | -36.8% | 58.9% | 24.3% | 53.7% | – | – | – | – |
| CapEx 5Y CAGR | -19.9% | 19.4% | 27.8% | – | – | – | – | – | – |
| Total assets 1Y growth | 0.36% | -9.2% | -27.7% | -20.6% | 20.3% | 273.1% | – | – | – |
| Total assets 3Y CAGR | -13.0% | -19.5% | -11.6% | 52.8% | – | – | – | – | – |
| Total assets 5Y CAGR | -8.9% | 18.5% | – | – | – | – | – | – | – |
| Total equity 1Y growth | 8.3% | -36.7% | -286.6% | -48.4% | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.